Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Varicella and JE Vaccine Co-administration
NCT01815073Phase 4Completed
- Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Start
- Mar 2013
- Primary completion
- Jul 2013
- Modality
- Live Attenuated Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of varicella virus vaccine live, Japanese encephalitis vaccine in varicella (VZV), Japanese encephalitis (JE), sponsored by Changchun Keygen Biological Products Co., Ltd.. Started Mar 2013; status: completed.
02
Drugs
varicella virus vaccine liveJapanese encephalitis vaccine
03
Conditions
varicella (VZV)Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01815073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815073.